Comparison of 11c-methionine, 11c-choline, and 18f-fluorodeoxyglucose-positron emission tomography for distinguishing glioma recurrence from radiation necrosis

Neurologia Medico-Chirurgica

Volumn 54, Issue 4, 2014, Pages 280-289

  Takenaka, Shunsuke ^a   Asano, Yoshitaka ^a,b   Shinoda, Jun ^a,b   Nomura, Yuichi ^a   Yonezawa, Shingo ^a   Miwa, Kazuhiro ^a   Yano, Hirohito ^b   Iwama, Toru ^b  

^a Kizawa Memorial Hospital   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Glioma; Positron emission tomography; Radiation necrosis

Indexed keywords

CHOLINE C 11; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE MEGLUMINE; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT; CARBON; CHOLINE; FLUORINE; METHIONINE;

ADULT; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC CAPACITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; RADIATION NECROSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; AGED; AREA UNDER THE CURVE; BRAIN; BRAIN NEOPLASMS; COMPARATIVE STUDY; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEUROIMAGING; PATHOLOGY; RADIATION INJURY; RADIATION RESPONSE; RETROSPECTIVE STUDY; SCINTISCANNING; TISSUE DISTRIBUTION;

ADULT; AGED; AREA UNDER CURVE; BRAIN; BRAIN NEOPLASMS; CARBON ISOTOPES; CHOLINE; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 84902242100     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.oa2013-0117     Document Type: Article

References (33)

1. Hein PA, Eskey CJ, Dunn JF, Hug EB: Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 25: 201-209, 2004
2. Sundgren PC, Fan X, Weybright P, Welsh RC, Carlos RC, Petrou M, McKeever PE, Chenevert TL: Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging 24: 1131-1142, 2006
3. Matsusue E, Fink JR, Rockhill JK, Ogawa T, Maravilla KR: Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology 52: 297-306, 2010
4. Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, Mikkelsen T: Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54: 1111-1117; discussion 1117-1119, 2004
5. Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH: Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 84: 63-69, 2007
6. Sonoda Y, Kumabe T, Takahashi T, Shirane R, Yoshimoto T: Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. Neurol Med Chir (Tokyo) 38: 342-347; discussion 347-348, 1998
7. Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith PL, Smith BH, Rizzoli HV, Kessler RM, Manning RG, Channing M, Wolf AP, O'Connor CM: Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 144: 885-889, 1982
8. Ogawa T, Kanno I, Shishido F, Inugami A, Higano S, Fujita H, Murakami M, Uemura K, Yasui N, Mineura K: Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 32: 197-202, 1991
9. Kim EE, Chung SK, Haynie TP, Kim CG, Cho BJ, Podoloff DA, Tilbury RS, Yang DJ, Yung WK, Moser RP: Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 12: 269-279, 1992
10. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP: Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19: 407-413, 1998
11. Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Nishikawa M, Ohata K, Torii K, Morino M, Nishio A, Hara M: Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery-in malignant glioma. Ann Nucl Med 18: 291-296, 2004
12. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K: Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49: 694-699, 2008
13. Singhal T, Narayanan TK, Jain V, Mukherjee J, Mantil J: 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 10: 1-18, 2008
14. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, Sasaki T: Brain tumour imaging with carbon-11choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 28: 1664-1670, 2001
15. Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T: Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29: 1176-1182, 2008
16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007
17. Sub-committee on Medical Application of Cyclotron-Produced Radionuclides, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association: Standards of Compounds Labeled with Positron Nuclides Approved as Established Techniques for Medical Use and Recommendations on Practices of Their Clinical Use (1999 revision). Radioisotopes 48: 65-90, 1999
18. Sub-committee on Medical Application of Cyclotron-Produced Radionuclides, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association: Standards of Compounds Labeled with Positron Nuclides Approved as Established Techniques for Medical Use and Recommendations on Practices of Their Clinical Use (Supplement of 1999 Revision). Radioisotopes 50: 38-41, 1999
19. Hudson HM, Larkin RS: Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 13: 601-609, 1994
20. Kapouleas I, Alavi A, Alves WM, Gur RE, Weiss DW: Registration of three-dimensional MR and PET images of the human brain without markers. Radiology 181: 731-739, 1991
21. Keyes JW: SUV: standard uptake or silly useless value? J Nucl Med 36: 1836-1839, 1995
22. Iuchi T, Hatano K, Narita Y, Kodama T, Yamaki T, Osato K: Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT. Int J Radiat Oncol Biol Phys 64: 1317-1324, 2006
23. Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA: Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. Int J Radiat Oncol Biol Phys 64: 892-897, 2006
24. Hermanto U, Frija EK, Lii MJ, Chang EL, Mahajan A, Woo SY: Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 67: 1135-1144, 2007
25. Miyatake S, Kawabata S, Yokoyama K, Kuroiwa T, Michiue H, Sakurai Y, Kumada H, Suzuki M, Maruhashi A, Kirihata M, Ono K: Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas. J Neurooncol 91: 199-206, 2009
26. Tanaka Y, Fujii M, Saito T, Kawamori J: [Radiation therapy for brain tumors]. Nippon Igaku Hoshasen Gakkai Zasshi 64: 387-393, 2004 (Japanese)
27. Gómez-Río M, Rodríguez-Fernández A, Ramos-Font C, López-Ramírez E, Llamas-Elvira JM: Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence. Eur J Nucl Med Mol Imaging 35: 966-975, 2008
28. Miwa K, Shinoda J, Yano H, Okumura A, Iwama T, Nakashima T, Sakai N: Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study. J Neurol Neurosurg Psychiatry 75: 1457-1462, 2004
29. Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H: Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 62: 329-338, 2003
30. Huang Z, Zuo C, Guan Y, Zhang Z, Liu P, Xue F, Lin X: Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours. Nucl Med Commun 29: 354-358, 2008
31. Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, Bormans G, Mortelmans L: Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 32: 39-51, 2005
32. Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T: 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47: 904-911, 2006
33. Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH: Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med 46: 945-952, 2005